Status:
NOT_YET_RECRUITING
Effect of Bee Venom on Chronic Kidney Disease-Mineral Bone Disorders in Hemodialysis Patients: a Randomized Controlled Trial
Lead Sponsor:
Mansoura University
Conditions:
Chronic Kidney Disease
Bee Venom
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
This study aims to evaluate the effectiveness of bee venom injections as a treatment for chronic kidney disease (CKD)-mineral bone disorder (MBD) in patients undergoing hemodialysis. MBD is a common c...
Detailed Description
This prospective, randomized controlled trial investigates the potential therapeutic role of bee venom in improving mineral bone disorder (MBD) among hemodialysis patients with chronic kidney disease ...
Eligibility Criteria
Inclusion
- Patients of both sexes aged 18 years and older.
- Patients undergoing maintenance hemodialysis three times weekly for at least six months.
- Patients who are not scheduled for kidney transplantation within the next year.
Exclusion
- Current pregnancy or lactation.
- Medical history of chronic conditions such as liver disease, cancer, or autoimmune diseases.
- Refusal to participate in the study.
- Active chronic infections, including HIV, HCV, HBV, and tuberculosis.
- Current use of medications affecting bone metabolism (e.g., calcitonin, denosumab, estrogen) within the last six months.
- History of renal allograft failure within the past year.
Key Trial Info
Start Date :
April 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 20 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06901102
Start Date
April 10 2025
End Date
October 20 2025
Last Update
March 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology and Nephrology Center, Mansoura University
Al Mansurah, Dakahliya, Egypt, 35111